title
stringlengths 16
122
| date
stringlengths 19
19
| content
stringlengths 255
1.95k
| tickers
stringlengths 0
186
| image
stringlengths 66
66
| link
stringlengths 66
171
| author
stringclasses 1
value | site
stringclasses 1
value |
|---|---|---|---|---|---|---|---|
What to Expect From The Boeing Company Q4 Results? | 2022-01-21 18:46:00 | <p>Analysts at RBC Capital provided their outlook on <a href='https://financialmodelingprep.com/financial-summary/BA'>The Boeing Company (NYSE:BA)</a> ahead of the company’s Q4 results, stating that they remain positive on the company into 2022.</p>
<p>The analysts do not expect the Q4 results to be a material catalyst, and they expect management to continue to withhold detailed financial guidance. However, the outlook for production and deliveries will likely be the most watched aspect of the quarterly results.</p>
<p>The analysts expect the company to take additional charges associated with 787 and potentially 777X, and we could see substantial de-risking of future estimates. However, the analysts noted that they do see Boeing becoming increasingly “investable” getting closer to positive FCF with improving industry fundamentals. </p>
| NYSE:BA | https://financialmodelingprep.com/market-news/fmp-what-to-expect-from-the-boeing-company-q4-results? | Davit Kirakosyan | Financial Modeling Prep |
|
Baker Hughes Company Reported Strong Q4 Results | 2022-01-21 18:44:00 | <p><a href='https://financialmodelingprep.com/financial-summary/BKR'>Baker Hughes Company (NASDAQ:BKR) </a>reported its Q4 results, highlighted by margins outperforming expectations in most segments. </p>
<p>Analysts at RBC Capital said they remain encouraged by the company's longer-term leverage to increased global natural gas and LNG demand, which should drive continued FCF in 2022 and onward. In 2022, the analysts anticipate 7% revenue growth alongside 20% adjusted EBITDA growth. The analysts increased their 2022 EBITDA estimate by 3% to $3.22 billion, primarily reflecting stronger operating income margins in TPS.</p>
| NASDAQ:BKR | https://financialmodelingprep.com/market-news/fmp-baker-hughes-company-reported-strong-q4-results | Davit Kirakosyan | Financial Modeling Prep |
|
Bitcoin Dropped Below $36,000, Mining Difficulty Reaches Lifetime High | 2022-01-21 18:40:00 | <p>Bitcoin price fell significantly during the last two days, dropping below $36,000 on Friday, which represents a more than a 45% decline since its November highs. This led to the market capitalization of the entire crypto-economy to drop to around $1.7 trillion.</p>
<p>Furthermore, bitcoin mining difficulty has reached its lifetime high of 26.643 trillion after jumping 9.32% at block height 719,712, meaning it's currently more difficult than ever before to find a block reward.</p>
| BTC-USD | https://financialmodelingprep.com/market-news/fmp-bitcoin-dropped-below-$36000-mining-difficulty-reaches-lifetime-high | Davit Kirakosyan | Financial Modeling Prep |
|
Peloton Interactive Shares Plummeted on Q2 Pre-Announcement | 2022-01-21 12:03:00 | <p><a href='https://financialmodelingprep.com/financial-summary/PTON'>Peloton Interactive, Inc. (NASDAQ:PTON) </a>shares plummeted around 24% on Thursday, before recovering slightly today (up 7% at the time of writing) following the company’s pre-announced weaker Q2 net adds. Quarterly pre-announced net adds were 12% below the Street estimates, resulting in connected fitness subs 1% below estimates. </p>
<p>The announcement follows press reports of Peloton halting production of bikes/treadmills due to oversupply, which the company is denying.</p>
<p>Analysts at Oppenheimer adjusted their price target on the company’s shares to $40 from $85, lowering 2022/2023 connected fitness subs by 4%/8%, to +39%/+30% year-over-year, implying 920,000/975,000 net adds, compared to 1.2 million in 2021.</p>
<p>However, the analysts maintained their Outperform rating as they believe the company will sustain its leadership position in connected fitness over the long term. </p>
| NASDAQ:PTON | https://financialmodelingprep.com/market-news/fmp-peloton-interactive-shares-plummeted-on-q2-pre-announcement- | Davit Kirakosyan | Financial Modeling Prep |
|
Why Sony Group Shares Declined 10% This Week? | 2022-01-21 11:59:00 | <p><a href='https://financialmodelingprep.com/financial-summary/SONY'>Sony Group Corporation (NYSE:SONY) </a>shares declined around 10% since the acquisition announcement of Activision Blizzard by Microsoft, as investors fear the deal will materially undermine PlayStation's competitiveness longer term. </p>
<p>While Xbox will become a more attractive gaming platform with Activision Blizzard, analysts at Oppenheimer believe investors' initial read-through for SONY is overly negative. The analysts believe Xbox and PS's first-party (1P) content strategies are driven by different purposes. Xbox prioritizes reach. PlayStation prioritizes differentiation. They view the deal as Xbox's attempt to expand its scale and reach across console, PC, and mobile platforms, not as a targeted weapon against PlayStation. </p>
<p>The analysts expect those different goals to result in less direct competition between the two platforms and enable both to benefit from secular industry growth. </p>
| NYSE:SONY | https://financialmodelingprep.com/market-news/fmp-why-sony-group-shares-declined-10-this-week? | Davit Kirakosyan | Financial Modeling Prep |
|
Strong Signs of Continued Growth for Bank of America Corporation | 2022-01-21 11:55:00 | <p>Berenberg Bank analysts provided their views on <a href='https://financialmodelingprep.com/financial-summary/BAC'>Bank of America Corporation (NYSE:BAC) </a>following the company’s recent Q4 results, which acted as a reminder of its relative strength versus peers. Most significantly, guidance for flat year-over-year costs during 2022 provided welcome relief versus peers’ elevated cost inflation. This efficiency has not, however, come at the expense of growth. Instead, indicators of future growth are robust, and the analysts believe the company’s business mix is particularly well suited to the recovery. </p>
<p>The analysts expect the company’s revenues to grow by 15% during the next three years. While much of this increase relates to the bank’s gearing to expected US interest rate rises, the analysts are also reassured by Bank of America’s recent growth. For instance, the bank’s commercial and consumer loan books both grew at a double-digit annualized rate during Q4/21 and by 14% overall. </p>
| NYSE:BAC | https://financialmodelingprep.com/market-news/fmp-strong-signs-of-continued-growth-for-bank-of-america-corporation | Davit Kirakosyan | Financial Modeling Prep |
|
V.F. Corporation Shares Down 5%, What to Expect From Q3 Results? | 2022-01-20 20:07:00 | <p><a href='https://financialmodelingprep.com/financial-summary/VFC'>V.F. Corporation (NYSE:VFC) </a>shares closed more than 5% lower on Thursday ahead of the company’s Q3 results, which are expected to be released on January 28.</p>
<p>Analysts at Deutsche Bank provided their outlook on the upcoming earnings results, expecting an in-line quarter, with EPS of $1.23 (vs. Street’s estimate of $1.22), driven by momentum in Outdoor with both The North Face and Timberland demonstrating strong results. </p>
<p>On the flip side, the analysts are cautious on Vans into the print as Omicron-related store restrictions around Holiday could weigh on the brand to a greater degree than the rest of the portfolio. </p>
| NYSE:VFC | https://financialmodelingprep.com/market-news/fmp-vf-corporation-shares-down-5-what-to-expect-from-q3-results? | Davit Kirakosyan | Financial Modeling Prep |
|
Mastercard Incorporated Q4 Preview by RBC Capital | 2022-01-20 20:02:00 | <p><a href='https://financialmodelingprep.com/financial-summary/MA'>Mastercard Incorporated (NYSE:MA) </a>will release its Q4 earnings results on January 27. Analysts at RBC Capital provided their outlook on the company ahead of the report, expecting revenue to grow 25% year-over-year to $5.14 billion. Quarterly EPS is expected to be $2.25, compared to the Street’s estimate of $2.21.</p>
<p>Overall, the analysts anticipate the company’s guidance for 2022 to remain largely in sync with mid-term (3-year) guidance provided during its November 10th analyst day – high-teens net revenue growth and EPS in the low 20%s.</p>
<p>The analysts believe the company is a core long-term holding and an “indexed” way to play payments and benefits from three global secular megatrends including 1) global consumption, 2) global digitization of payments, and 3) global innovation, which is creating new payment flows.</p>
| NYSE:MA | https://financialmodelingprep.com/market-news/fmp-mastercard-incorporated-q4-preview-by-rbc-capital | Davit Kirakosyan | Financial Modeling Prep |
|
Jim Cramer Says SEC Will Regulate Dogecoin, Warns About Investing | 2022-01-20 19:58:00 | <p>Jim Cramer, the host of CNBC’s Mad Money and former hedge fund manager who co-founded Thestreet.com, tweeted about Dogecoin, warning investors to be careful with it. Cramer said that the popular meme coin is a security and will be regulated by SEC, as well as questioned the supply of dogecoin.</p>
<p>Many users argued with Cramer on Twitter, questioning the fact that dogecoin, currently the 11th largest cryptocurrency by market cap, is a security. Some even slammed him for his lack of knowledge of blockchains and the meme coin’s supply.</p>
| DOGE-USD | https://financialmodelingprep.com/market-news/fmp-jim-cramer-says-sec-will-regulate-dogecoin-warns-about-investing | Davit Kirakosyan | Financial Modeling Prep |
|
How Microsoft Benefits From its $69.7 Billion Activision Blizzard Acquisition ? | 2022-01-20 16:31:00 | <p>On January 18, <a href='https://financialmodelingprep.com/financial-summary/MSFT'>Microsoft Corporation (NASDAQ:MSFT) </a>has announced its plan to acquire <a href='https://financialmodelingprep.com/financial-summary/ATVI'>Activision Blizzard, Inc. (NASDAQ:ATVI) </a>in an all-cash transaction worth $95.00 per share, which makes the deal worth $69.7 billion.</p>
<p>While Microsoft outlined its belief that Activision Blizzard will prove a strong asset in building a metaverse product, the IP that Microsoft will be acquiring should have an immediate impact. First, adding games such as Call of Duty to the Game Pass portfolio should provide a major boost to the current subscriber base. Furthermore, the Activision Blizzard portfolio will significantly boost the diversity of Microsoft games, particularly in terms of mobile and free-to-play (F2P) content, areas in which Microsoft has not yet built a strong presence.</p>
<p>While the analysts at Berenberg Bank believe there is a strong chance that this deal will complete (exp. 2023), they acknowledge that elements to lead to questions and concerns from regulators is the fact that following completion of the deal, Microsoft could theoretically make all Activision Blizzard console games Xbox exclusives, which would be very damaging for PlayStation and therefore Sony. </p>
| NASDAQ:ATVI, NASDAQ:MSFT | https://financialmodelingprep.com/market-news/fmp-how-microsoft-benefits-from-its-$697-billion-activision-blizzard-acquisition-? | Davit Kirakosyan | Financial Modeling Prep |
|
Texas Instruments' Q4 Preview | 2022-01-20 16:26:00 | <p>Analysts at Deutsche Bank provided their views on <a href='https://financialmodelingprep.com/financial-summary/TXN'>Texas Instruments Incorporated (NASDAQ:TXN) </a>ahead of the company’s Q4 results, expected to be reported on January 25. The analysts expect the company to deliver another revenue beat and raise, albeit with the size of that beat/raise once again smaller than the large beats the company delivered throughout much of 2021.</p>
<p>On the demand front, the analysts expect the company to provide incremental color around customer behavior patterns, with particular commentary around expedite/cancellation trends, the pervasiveness of hotspots, and any signs of a slowdown in demand or increase in "customer selectivity".</p>
| NASDAQ:TXN | https://financialmodelingprep.com/market-news/fmp-texas-instruments-q4-preview | Davit Kirakosyan | Financial Modeling Prep |
|
Varonis Systems Long-Term Opportunity is Underappreciated by The Market | 2022-01-20 16:24:00 | <p>Analysts at Berenberg Bank believe the market underappreciates the long-term opportunity of <a href='https://financialmodelingprep.com/financial-summary/VRNS'>Varonis Systems, Inc. (NASDAQ:VRNS)</a>, noting that the company, market leader in the data security category, is well-positioned to take a share of security budgets as organizations place increased focus on data security, as many employees around the world have had to work remotely or in a hybrid capacity over the last 18+ months.</p>
<p>The analysts mentioned several tailwinds that can sustain the durable growth of the company, such as the elevated threat environment, a robust product offering with little competition, and an expansion of its TAM with 10 DatAdvantage Cloud licenses that protect highly relevant and popular cloud data repositories.</p>
| NASDAQ:VRNS | https://financialmodelingprep.com/market-news/fmp-varonis-systems-long-term-opportunity-is-underappreciated-by-the-market | Davit Kirakosyan | Financial Modeling Prep |
|
Exxon Mobil Corporation Upgraded to Sector Perform by RBC Capital | 2022-01-19 19:57:00 | <p>Analysts at RBC Capital upgraded <a href='https://financialmodelingprep.com/financial-summary/XOM'>Exxon Mobil Corporation (NYSE:XOM)</a> to Sector Perform From Underperform and raised their price target on the company’s shares to $90 from $70. The upgrade on the company, which saw its shares price increase almost 20% since the start of this year, was a result of the brokerage believing its underperform rating is no longer warranted, given the overall tailwinds for the sector to likely outweigh company-specific factors in 2022. </p>
<p>According to the analysts, the company has moved from the brink of a potential dividend cut in the depths of the COVID-19 pandemic to a more balanced financial framework in 2021, and significant free cash flow potential in 2022, driven by booming commodity prices. The analysts admitted they were wrong on the company last year, and missed the powerful upgrades coming through, particularly for its Chemicals business.</p>
| https://financialmodelingprep.com/market-news/fmp-exxon-mobil-corporation-upgraded-to-sector-perform-by-rbc-capital | Davit Kirakosyan | Financial Modeling Prep |
||
RBC Capital Price Target Lowered Following Q4 Pre-Announcement | 2022-01-19 19:55:00 | <p>Analysts at RBC Capital lowered their price target on <a href='https://financialmodelingprep.com/financial-summary/SHW'>The Sherwin-Williams Company (NYSE:SHW)</a> to $332 from $360 on the company’s Q4 pre-announcement, persistent cost inflation and labor shortages. </p>
<p>According to the pre-announcement, Q4 net sales grew around 6.1% year-over-year and adjusted EPS is expected to be around $1.45 per share. The brokerage mentioned that its estimates reflect continued inflationary pressures across the company’s supply chain, labor and raw material availability headwinds, offset by continued strong demand throughout 2022 and pricing actions.</p>
<p>The analysts added that they still believe the company represents a margin expansion opportunity in the second half of 2022 and in 2023, when cost pressures begin to moderate and pricing action remains in place.</p>
| NYSE:SHW | https://financialmodelingprep.com/market-news/fmp-rbc-capital-price-target-lowered-following-q4-pre-announcement | Davit Kirakosyan | Financial Modeling Prep |
|
Gold is Better Than Crypto as an Inflation Hedge | 2022-01-19 19:53:00 | <p>While some analysts expect gold prices to be around $1,683 in Q4/22, Mark Bristow, the CEO of Canada-based Barrick Gold Corp, believes that the precious metal currently has a little downside risk and it is a better store-of-value alternative compared to cryptocurrencies.</p>
<p>Bristow, who recently suggested that “no one believes in fiat anymore”, says that he still believes gold is preferable to cryptocurrencies as a hedge against inflation.</p>
| BTCUSD | https://financialmodelingprep.com/market-news/fmp-gold-is-better-than-crypto-as-an-inflation-hedge | Davit Kirakosyan | Financial Modeling Prep |
|
Progress Software Corporation Shares Down 5% Despite Strong Q4 Results | 2022-01-19 16:04:00 | <p><a href='https://financialmodelingprep.com/financial-summary/PRGS'>Progress Software Corporation (NASDAQ:PRGS) </a>shares closed more than 5% lower on Wednesday, despite the company’s reported strong Q4 results, with EPS coming in at $0.92, beating the consensus estimate of $0.74. Quarterly revenue was $143.7 million, compared to the Street estimate of $135.4 million. The company benefited from an accommodative spending environment and strong demand for its products (OpenEdge, DevTool, Ipswitch, and DataDirect). </p>
<p>On the negative side, margins are expected to remain under pressure in the near term as Kemp is integrated. Despite these expected near-term headwinds, the analysts at Oppenheimer are confident that management can continue its execution and capitalize on a strong acquisition pipeline to reach $1 billion in annual revenue by 2025.</p>
| NASDAQ:PRGS | https://financialmodelingprep.com/market-news/fmp-progress-software-corporation-shares-down-5-despite-strong-q4-results | Davit Kirakosyan | Financial Modeling Prep |
|
Entegris, Inc Share Price Is Expected to Rise | 2022-01-19 16:01:00 | According to the analysts at Deutsche Bank, the underperformance of <a href='https://financialmodelingprep.com/financial-summary/ENTG'>Entegris, Inc. (NASDAQ:ENTG) </a>shares vs. peers since the acquisition announcement of CMC Materials on Dec 15, was driven by investors’ concern regarding the increased leverage from the proposed acquisition in a rising rate environment, as well as some uncertainties around the non-semis business of CMC Materials.</p>
<p>The analysts continue to believe the deal could be accretive to the company’s EPS by around 15% in the first year following closing, seeing the potential for additional accretion from revenue synergies. </p>
<p>As the analysts believe the pressure since the deal announcement is overdone, it upgraded the company to buy from hold, maintaining its $160 price, which represents a potential 25% upside.</p>
| NASDAQ:ENTG | https://financialmodelingprep.com/market-news/fmp-entegris-inc-share-price-is-expected-to-rise- | Davit Kirakosyan | Financial Modeling Prep |
|
Optimistic Outlook For Halozyme in 2022 | 2022-01-19 15:59:00 | <p><a href='https://financialmodelingprep.com/financial-summary/HALO'>Halozyme Therapeutics, Inc. (NASDAQ:HALO)</a> increased its revenue guidance for 2022, expecting total revenue to be in the range of $530-560 million, representing 23-26% growth year-over-year. The company’s primary revenue stream is from royalties, which are expected to increase approximately 244% from 2020 and 50% year-over-year to $300 million.</p>
<p>Analysts at Berenberg Bank expect strong growth in royalty revenues to be largely driven by DARZALEX and Phesgo for the near term until the next set of product launches debut in the 2023-25 timeframe, assuming a positive outcome from the Phase III studies, results of which are expected in 2022-23.</p>
| NASDAQ:HALO | https://financialmodelingprep.com/market-news/fmp-optimistic-outlook-for-halozyme-in-2022 | Davit Kirakosyan | Financial Modeling Prep |
|
Why Did JPMorgan Chase & Co Share Price Drop 10%? | 2022-01-18 19:39:00 | <p><a href='https://financialmodelingprep.com/financial-summary/JPM'>JPMorgan Chase & Co. (NYSE:JPM) </a>shares lost around 10% since Thursday, driven by the company’s updated outlook provided during its Q4 earnings call.</p>
<p>While the company posted quarterly EPS of $3.33, coming in better than the consensus estimate of $3.01, the investors were discouraged as the company made it clear their maintained medium-term 17% ROTCE target is not expected to be there in 2022 because of investment spending. Before the results, 2022 and 2023 Street EPS estimates of $12.06 and $13.38, respectively, both implied around 17% ROTCE. The Street expected 2022 expense of around $73 billion, and the new guidance was $77 billion. This was a negative surprise for investors, which resulted in a significant stock price fall.</p>
| NYSE:JPM | https://financialmodelingprep.com/market-news/fmp-why-did-jpmorgan-chase-&-co-share-price-drop-10? | Davit Kirakosyan | Financial Modeling Prep |
|
Vale S.A. Upgraded to Sector Perform at RBC Capital | 2022-01-18 19:35:00 | <p>The company's weak Q3 results reported in Nov 1 and Vale Day guidance saw <a href='https://financialmodelingprep.com/financial-summary/VALE'>Vale S.A. (NYSE:VALE) </a>shares sell off and consensus earnings fall, but the rally in iron ore prices has since provided some support. </p>
<p>Analysts at RBC Capital increased their long-term iron ore price forecasts to $75/t from $65/t. This and a weaker BRL assumption helps to increase their NAV estimate by 39% to $20.49/share. The analysts believe Brazil risks, its EM link, and concentration in iron ore will continue to see shares discounted, however, the stock should be more resilient into future iron ore downturns. The analysts upgraded the company to sector perform from underperform, raising their price target to $17 from $12.50.</p>
| NYSE:VALE | https://financialmodelingprep.com/market-news/fmp-vale-sa-upgraded-to-sector-perform-at-rbc-capital | Davit Kirakosyan | Financial Modeling Prep |
|
Hilton Worldwide Holdings Will Benefit From Faster Covid-19 Recovery in the U.S. | 2022-01-18 19:33:00 | <p>Berenberg Bank raised its price target on <a href='https://financialmodelingprep.com/financial-summary/HLT'>Hilton Worldwide Holdings Inc. (NYSE:HLT)</a> to $140 from $110 due to a faster-than-expected recovery in the US. </p>
<p>The company, with its heavy US exposure, is expected to benefit from the more rapid recovery from COVID-19. While the analysts mentioned their surveys suggest there will be some limited structural decline in domestic business travel, it will broadly hold up strongly with pricing set to be better-than-expected.</p>
| NYSE:HLT | https://financialmodelingprep.com/market-news/fmp-hilton-worldwide-holdings-will-benefit-from-faster-covid-19-recovery-in-the-us | Davit Kirakosyan | Financial Modeling Prep |
|
Netflix’s Price Target Lowered Ahead of Q4 Results | 2022-01-18 17:34:00 | <p>Deutsche Bank analysts lowered their price target on <a href='https://financialmodelingprep.com/financial-summary/NFLX'>Netflix, Inc. (NASDAQ:NFLX)</a> to $580 from $590 ahead of the company’s Q4 results, expected to be reported on Jan 20.</p>
<p>The analysts lowered their Q4 Net Add estimate to 7.25 million (vs, Street estimate of 8.5 million) as a result of their analysis of Google trends data. While the analysts don't think the 8.5 million consensus estimate is completely off the table, they view it as the best case, but assigning it a very low probability.</p>
| NASDAQ:NFLX | https://financialmodelingprep.com/market-news/fmp-netflix’s-price-target-lowered-ahead-of-q4-results | Davit Kirakosyan | Financial Modeling Prep |
|
Citigroup Reported Better-Than-Expected Q4 Results | 2022-01-18 17:31:00 | <p><a href='https://financialmodelingprep.com/financial-summary/C'>Citigroup Inc. (NYSE:C) </a>reported its Q4 results, which came in better than expected and provided some reassurance about the company’s outlook, following 25% underperformance versus US banks during last year. The company’s quarterly revenue came in at $17 billion, beating the Street estimate of $16.75 billion. </p>
<p>While lower-than-expected loan-loss charges accounted for most of the company’s earnings strength, the bank’s net interest income was 4% better than expected. </p>
<p>The continuing recovery of Citigroup’s credit card volumes also appears stronger than for some peers. This, and potential benefits from rising US interest rates, should increasingly support the bank’s domestic consumer revenues.</p>
| NYSE:C | https://financialmodelingprep.com/market-news/fmp-citigroup-reported-better-than-expected-q4-results | Davit Kirakosyan | Financial Modeling Prep |
|
Fidelity Anticipates More Countries/Central Banks to Acquire Bitcoin | 2022-01-17 13:10:00 | <p>According to the report by Fidelity Digital Assets, a subsidiary of Fidelity Investments, more sovereign nation-states (perhaps central banks) may acquire bitcoin in 2022.</p>
<p>According to the report, last year’s major moves by world governments regarding digital assets, from China banning cryptocurrencies to El Salvador making a BTC legal tender, couldn’t be more opposed. While stating that now it is difficult to be certain which direction is more successful, the authors said that an outright ban will be difficult to achieve at best, and will lead to substantial wealth loss, if successful. </p>
<p>The authors believe that if bitcoin adoption grows, the countries that secure some bitcoin today will be better off in the future, and therefore, even if the countries that don’t believe in the adoption of bitcoin, will be forced to acquire some as a form of insurance.</p>
| BTCUSD | https://financialmodelingprep.com/market-news/fmp-fidelity-anticipates-more-countriescentral-banks-to-acquire-bitcoin- | Davit Kirakosyan | Financial Modeling Prep |
|
Kosmos Energy Outlook Ahead of Q4 Results | 2022-01-17 13:06:00 | <p>Analysts at Berenberg Bank provided their outlook on <a href='https://financialmodelingprep.com/financial-summary/KOS'>Kosmos Energy Ltd. (NYSE:KOS)</a> ahead of the upcoming Q4 results.</p>
<p>The analysts expect the company to materially reduce its net debt in 2022, falling 20% from their year-end 2021 forecast of $2.5 billion to $2.0 billion at year-end 2022. Strong oil prices should also significantly improve EBITDAX (the analysts expect $1.2 billion in 2022 versus $600 million in 2021), contributing to leverage falling to 1.5x from 3.6x.</p>
<p>The analysts are encouraged by the improvement in performance at the Jubilee and TEN fields in the past 12 months, highlighting the increased confidence in the long-term outlook for the assets. </p>
<p>The analysts anticipate Q4 EPS to come in at $0.16, which is around 33% ahead of the Street estimate.</p>
| NYSE:KOS | https://financialmodelingprep.com/market-news/fmp-kosmos-energy-outlook-ahead-of-q4-results | Davit Kirakosyan | Financial Modeling Prep |
|
VMware Review by RBC Capital | 2022-01-14 21:10:00 | <p>Analysts at RBC Capital commented on <a href='https://financialmodelingprep.com/financial-summary/VMW'>VMware, Inc. (NYSE:VMW)</a>, which saw its share price increase around 8% since the start of the year, following their call with CEO Raghu Raghuram and CFO Zane Rowe.</p>
<p>During the call management highlighted key themes surrounding the company's increasing market opportunity and the growth of its Subscription and SaaS (S&S) offerings as the industry moves into a new phase of digital transformation. Management remains bullish on their S&S product portfolio and its rate of adoption, breaking down their offerings into three buckets: S&S products, products that can be sold either on a perpetual basis or S&S, and products not yet available as a S&S offering. With this as a backdrop, management is optimistic about the receptivity of their portfolio as the company doubles down on its S&S go-to-market focus.</p>
| NYSE:VMW | https://financialmodelingprep.com/market-news/fmp-vmware-review-by-rbc-capital | Davit Kirakosyan | Financial Modeling Prep |
|
Dogecoin Price Surges as Tesla Begins Accepting it For Merchandise Purchases | 2022-01-14 21:07:00 | <p>Dogecoin price soared around 10% on Friday following Elon Musk’s tweet, according to which Tesla merchandise can now be purchased with dogecoin. While the coin lost most of its gains afterward, it is still trading around $0.1913 (up 4.14%) at the time of writing this article.</p>
<p>Musk delivered on his promise made last month that Tesla will accept dogecoin as payment and now it gives customers an option to buy selected merchandise with dogecoin. Meanwhile, the company has still not resumed accepting bitcoin.</p>
| DOGEUSD | https://financialmodelingprep.com/market-news/fmp-dogecoin-price-surges-as-tesla-begins-accepting-it-for-merchandise-purchases- | Davit Kirakosyan | Financial Modeling Prep |
|
Energy Transfer’s Review Following The Acquisition of Enable Midstream | 2022-01-14 21:04:00 | <p>Analysts at RBC Capital updated their estimates and raised their price target on <a href='https://financialmodelingprep.com/financial-summary/ET'>Energy Transfer LP (NYSE:ET) </a>to $14 from $9, following the acquisition of Enable Midstream, completed on December 2, 2021. </p>
<p>The analysts view the acquisition favorably given the complementary asset bases, synergy potential, positive impact on credit metrics, and increase in fee-based cash flow that it provides. </p>
<p>The company anticipates the acquisition to generate $100 million of cost and efficiency synergies, which the analysts view as achievable given the complementary asset bases.</p>
<p>According to the analysts, the company offers investors a compelling value proposition, given its expansive asset footprint across the hydrocarbon value chain, strengthening the balance sheet, and free cash flow generation.</p>
| NYSE:ET | https://financialmodelingprep.com/market-news/fmp-energy-transfer’s-review-following-the-acquisition-of-enable-midstream | Davit Kirakosyan | Financial Modeling Prep |
|
Frequency Therapeutics’ Outlook by Oppenheimer | 2022-01-14 21:02:00 | <p>Analysts at Oppenheimer provided their views on <a href='https://financialmodelingprep.com/financial-summary/FREQ'>Frequency Therapeutics, Inc. (NASDAQ:FREQ) </a>following their discussion with the company’s management regarding recent progress and anticipated milestones. </p>
<p>The new Ph2b 208 study is going well and the company expects to complete patient enrollment (N=124) in Q3/22, with top-line data expected in Q4/22 or early-2023. </p>
<p>At the recent R&D event, the company disclosed two new clinical candidates from the proprietary PCA platform. The follow-on molecule for hearing loss, FX-345, is expected to enter the clinic in the second half of this year with data expected in the first half of 2023. For the MS program, the company will select a candidate in 2022 and start a clinical trial in 2023. </p>
<p>According to the analysts, the company's $160 million cash and cash equivalents as of the end of Q3/21 should provide a financial runway into year-end 2023.</p>
| NASDAQ:FREQ | https://financialmodelingprep.com/market-news/fmp-frequency-therapeutics’-outlook-by-oppenheimer | Davit Kirakosyan | Financial Modeling Prep |
|
The Boston Beer Company Shares Dropped 8% on 2021 Guidance Cut | 2022-01-14 16:58:00 | <p><a href='https://financialmodelingprep.com/financial-summary/SAM'>The Boston Beer Company, Inc. (NYSE:SAM)</a> shares closed more than 8% lower on Friday, following the company’s published ad-hoc statement yesterday. The company cut its full 2021-year guidance again, now expecting EPS in the range of -$1.00 to $1.00, compared to the prior range of $2.00 - 6.00, reflecting weaker shipment growth from increased wholesaler destocking, and the gross margin impact of heightened supply-chain pressures.</p> | NYSE:SAM | https://financialmodelingprep.com/market-news/fmp-the-boston-beer-company-shares-dropped-8-on-2021-guidance-cut | Davit Kirakosyan | Financial Modeling Prep |
|
Delta Air Lines Reported Better-Than-Expected Q4 Results | 2022-01-14 16:54:00 | <p><a href='https://financialmodelingprep.com/financial-summary/DAL'>Delta Air Lines, Inc. (NYSE:DAL) </a>reported its Q4 results, with EPS coming in at $0.22, beating the Street estimate of $0.14. Quarterly revenue was $9.47 billion, compared to the consensus estimate of $9.21 billion.</p>
<p>Adjusted pretax profit was $170 million, compared to the company’s guidance of around $200 million (but that was prior to an operationally challenging year-end due to Omicron and weather-related cancellations), representing the company’s second consecutive profitable quarter since the onset of the pandemic.</p>
| NYSE:DAL | https://financialmodelingprep.com/market-news/fmp-delta-air-lines-reported-better-than-expected-q4-results | Davit Kirakosyan | Financial Modeling Prep |
|
Coinbase Acquires FairX to Enter Into Crypto Derivatives | 2022-01-13 23:49:00 | <p><a href='https://financialmodelingprep.com/financial-summary/COIN'>Coinbase Global, Inc. (NASDAQ:COIN) </a>made an announcement on Wednesday, according to which it is acquiring FairX, a CFTC- regulated derivatives exchange, with a transaction expected to close in Q1/22.</p>
<p>According to RBC Capital analysts, the company has a strong balance sheet with $6.4 billion in cash to make acquisitions for diversification, and derivatives in an area that is a logical extension to its business model and has a large addressable market. </p>
<p>The company plans to offer its derivatives products through FairX’s existing partner ecosystem such as TD Ameritrade, E*Trade and Virtu and over time leverage FairX’s infrastructure to offer crypto derivatives to all its US customers.</p>
| NASDAQ:COIN | https://financialmodelingprep.com/market-news/fmp-coinbase-acquires-fairx-to-enter-into-crypto-derivatives | Davit Kirakosyan | Financial Modeling Prep |
|
What to Expect From UnitedHealth Group Q4 Results? | 2022-01-13 23:46:00 | <p>Analysts at RBC Capital provided their views on <a href='https://financialmodelingprep.com/financial-summary/UNH'>UnitedHealth Group Incorporated (NYSE:UNH) </a>ahead of the company’s Q4 results, expected to be reported on Jan 19.</p>
<p>The analysts slightly adjusted their model to better reflect management's final 2021 guidance views offered at its November 30 Investor Day. The analysts increased their quarterly revenue estimate to $73.0 billion from $71.5 billion, which primarily reflects higher OptumHealth revenue. </p>
<p>The analysts kept their 2021 adjusted EPS unchanged at $4.32, and continue to expect 2022 adjusted EPS of $21.34, which approximates the midpoint of management's initial guide for this year.</p>
| NYSE:UNH | https://financialmodelingprep.com/market-news/fmp-what-to-expect-from-unitedhealth-group-q4-results? | Davit Kirakosyan | Financial Modeling Prep |
|
CF Industries Holdings Downgraded to Hold From Buy Following its Strong Run in 2021 | 2022-01-13 17:34:00 | <p>Analysts at Berenberg Bank downgraded <a href='https://financialmodelingprep.com/financial-summary/CF'>CF Industries Holdings, Inc. (NYSE:CF) </a>to hold from buy as they believe the scope for further surprise is limited as energy spreads between the US and the rest of the world should narrow from record levels.</p>
<p>Although the analysts expect the company to do well in 2022, they believe that this is well known and understood at this stage. The company will benefit from rising UAN prices and better utilization of its asset base compared with last year (CF Industries outperformed its peers in 2021 thanks to record energy spreads).</p>
<p>Coal prices in China have already declined from Q3/21 highs while the European natural gas pricing situation remains the wild card, which could trigger the return of c11 mtpa of nitrogen volumes. With consensus assuming more than USD500/t urea pricing for 2022, the analysts struggle to find a further upside to EBITDA estimates.</p>
| NYSE:CF | https://financialmodelingprep.com/market-news/fmp-cf-industries-holdings-downgraded-to-hold-from-buy-following-its-strong-run-in-2021 | Davit Kirakosyan | Financial Modeling Prep |
|
Oppenheimer Downgrades Qorvo to Perform on Limited Near-Term Opportunities | 2022-01-13 17:31:00 | <p><a href='https://financialmodelingprep.com/financial-summary/QRVO'>Qorvo, Inc. (NASDAQ:QRVO) </a>was downgraded at Oppenheimer to Perform from Outperform given the lack of obvious growth/upside near-term catalysts. </p>
<p>The analysts mentioned that their upgrade on the company in July 2020 was mainly driven by the 5G RAN content/share gains expectations, however, 5G upside has been slow to materialize. </p>
<p>The analysts believe that Handset (the company is now 80% exposed to handset/mobile) is a large market with 1.6 billion units/year, but it is largely an ex-growth mature market with component suppliers dependent on sustained content gains for growth. </p>
<p>The analysts see limited content gains for the company this year, with content opportunities limited at Apple and increased competition from QUALCOMM Incorporated in China Android.</p>
| NASDAQ:QRVO | https://financialmodelingprep.com/market-news/fmp-oppenheimer-downgrades-qorvo-to-perform-on-limited-near-term-opportunities | Davit Kirakosyan | Financial Modeling Prep |
|
Earthstone Energy Q4 Preview | 2022-01-13 17:28:00 | <p>Analysts at RBC Capital provided their earnings preview on <a href='https://financialmodelingprep.com/financial-summary/ESTE'>Earthstone Energy, Inc. (NYSE:ESTE)</a>, updating their quarterly estimates, which reflect final commodity prices and other changes based on channel checks, data analytics, and conversations with the company. </p>
<p>The analysts expect Q4/21 EPS/CFPS to come in at $0.38/$0.81, an increase of $0.02/$0.04 from their prior estimates. The consensus estimate for CFPS stands at $0.83.</p>
<p>According to the analysts, 2022 plans shouldn't deviate much from pro forma guidance that includes the announced Chisholm acquisition and expect M&A to remain a core focus to scale the business accretively.</p>
| NYSE:ESTE | https://financialmodelingprep.com/market-news/fmp-earthstone-energy-q4-preview- | Davit Kirakosyan | Financial Modeling Prep |
|
American Equity Investment Life Holding Q4 Earnings Preview | 2022-01-13 00:09:00 | <p>Analysts at RBC Capital provided their outlook on <a href='https://financialmodelingprep.com/financial-summary/AEL'>American Equity Investment Life Holding Company (NYSE:AEL) </a>ahead of the company’s Q4 results, expected to be reported in mid-February.</p>
<p>The brokerage raised its Q4 EPS estimate to $1.00 from $0.92 which reflects modestly lower DAC amortization, higher reserve financing savings and other small adjustments to asset flows and yield assumptions. For the full 2021-year the analysts now estimate EPS of $3.26, up from $3.18 prior, with no adjustments to their 2022 and 2023 estimates.</p>
<p>The analysts increased their price target on the company’s shares to $47 from $41 in view of the company's recently closed equity placement with Brookfield Reinsurance.</p>
| NYSE:AEL | https://financialmodelingprep.com/market-news/fmp-american-equity-investment-life-holding-q4-earnings-preview | Davit Kirakosyan | Financial Modeling Prep |
|
Denny's Corporation Q4 Preliminary Results Came in Ahead of Expectations | 2022-01-13 00:08:00 | <p><a href='https://financialmodelingprep.com/financial-summary/DENN'>Denny's Corporation (NASDAQ:DENN) </a>announced its preliminary Q4 results, with domestic co-owned same-store sales growth coming in at 58.6% and franchised at 48.3%, compared to the consensus estimates of 57.3% and 47.9%, respectively.</p>
<p>Analysts at Wedbush believe the difference in company same-store sales growth vs. franchised same-store sales growth is due to better staffing levels (including a higher percentage of 24/7 locations) and a catch up in average check as they believe franchisees may have been more aggressive with respect to menu price increases earlier in the year. </p>
<p>The analysts maintained their outperform rating and $20 price target on the company’s shares, stating that they continue to believe the company's current valuation does not fully reflect management's ability to deliver post-COVID growth above pre-COVID growth rates. </p>
| NASDAQ:DENN | https://financialmodelingprep.com/market-news/fmp-dennys-corporation-q4-preliminary-results-came-in-ahead-of-expectations | Davit Kirakosyan | Financial Modeling Prep |
|
Swiss Bank Seba Expects $75,000 Bitcoin Price | 2022-01-13 00:05:00 | <p>Guido Buehler, the CEO of Seba Bank, digital assets banking platform, provided his predictions regarding Bitcoin prices during Crypto Finance Conference in St. Moritz, Switzerland.</p>
<p>According to Buehler, Seba Bank’s internal valuation model indicates a Bitcoin price between $50,000 and $75,000. He said he is quite confident prices will hit those levels, noting that the question is always timing. He also added that institutional investors will help drive Bitcoin prices in 2022.</p>
| BTCUSD | https://financialmodelingprep.com/market-news/fmp-swiss-bank-seba-expects-$75000-bitcoin-price- | Davit Kirakosyan | Financial Modeling Prep |
|
Berenberg Bank Initiated Coverage on Squarespace, Expects 40% Upside | 2022-01-12 15:58:00 | <p>Analysts at Berenberg Bank initiated coverage on <a href='https://financialmodelingprep.com/financial-summary/SQSP'>Squarespace, Inc. (NYSE:SQSP)</a>, a SaaS-based web development platform that enables small and medium businesses to create and grow their digital presence, with a buy rating and $42 price target, which implies over 40% upside. </p>
<p>Analysts believe the company, with around 4 million unique subscriptions and $621 million generated revenue in 2020, is well-positioned to benefit from turning professional-grade web design and development into a mass-market DIY product, tapping into a $150-$180 billion TAM. With its strong market share, the company is also believed to be well-positioned to benefit from any potential consolidation scenarios.</p>
| NYSE:SQSP | https://financialmodelingprep.com/market-news/fmp-berenberg-bank-initiated-coverage-on-squarespace-expects-40-upside | Davit Kirakosyan | Financial Modeling Prep |
|
SmartRent Reported Better-Than-Expected Preliminary Q4 Results | 2022-01-12 15:55:00 | <p><a href='https://financialmodelingprep.com/financial-summary/SMRT'>SmartRent, Inc. (NYSE:SMRT) </a>reported its preliminary Q4 results, which came in above the Street expectations. The strong revenue and KPIs for the quarter are encouraging, given the supply chain challenges that impacted results last quarter. </p>
<p>Considering the strong units booked (around 84,000) in the quarter and the number of deployed units, analysts at Deutsche Bank see upside risk for committed units in Q4 with regard to their estimate of around 723,000. </p>
<p>The analysts expect the full 2022-year outlook along with Q4 hosted services ARPU to be the key areas of focus going into earnings in March, but they believe this business update will alleviate some concerns about supply chain disruptions in Q4 and into 2022.</p>
| NYSE:SMRT | https://financialmodelingprep.com/market-news/fmp-smartrent-reported-better-than-expected-preliminary-q4-results | Davit Kirakosyan | Financial Modeling Prep |
|
Veeco Instruments Preview Following The Company’s Updated 2022 Outlook | 2022-01-12 15:53:00 | <p>Analysts at Oppenheimer provided their outlook on <a href='https://financialmodelingprep.com/financial-summary/VECO'>Veeco Instruments Inc. (NASDAQ:VECO) </a>ahead of the company’s Q4 results, which are planned to be released in mid-February.</p>
<p>Following the company’s filed SEC 8-K Form with 2022 outlook, the analysts raise their estimates and price target on the company’s shares to $38 from $34.</p>
<p>Management sees 2022 sales up 14% to $660 million, ahead of the consensus estimate of $642 million.</p>
<p>The analysts expect a beat/raise set up compared to the Street estimates of Q4 sales/EPS of $151 million/$0.37 and Q1 $149 million/$0.34. The analysts see possible upside in the second half of the year as the segment is expected to recover going into 2023.</p>
| NASDAQ:VECO | https://financialmodelingprep.com/market-news/fmp-veeco-instruments-preview-following-the-company’s-updated-2022-outlook | Davit Kirakosyan | Financial Modeling Prep |
|
NovoCure Limited Outlook Following Pre-Announced Q4 Revenue Miss | 2022-01-11 22:48:00 | <p>Analyst at Oppenheimer spoke with <a href='https://financialmodelingprep.com/financial-summary/NVCR'>NovoCure Limited (NASDAQ:NVCR)</a> management following the company’s pre-announced Q4 revenue, which came in at $133.2 million, missing the consensus estimate of $152.5 million.</p>
<p>The key takeaways of the meeting include the following:</p>
<p>(1) While the miss was across geographies, EMEA accounted for the largest miss due in part to a $4 million impact from new contracting in Germany.</p>
<p>(2) 2022 active user growth of 2-5% implies a downward revision to Oppenheimer’s revenue estimates.</p>
<p>(3) limited disruption to clinical trials from COVID. </p>
<p>The analysts lowered their GBM estimates across geographies for 2022 and beyond, now expecting total 2022 sales to be $561.5 million, compared to their previous $619.9 million estimate. While the analysts maintained their Perform rating, they view risk/reward outlook as improving and are focused on Metis study as an attractive path to the intermediate-term upside.</p>
| NASDAQ:NVCR | https://financialmodelingprep.com/market-news/fmp-novocure-limited-outlook-following-pre-announced-q4-revenue-miss | Davit Kirakosyan | Financial Modeling Prep |
|
Unum Group Outlook Ahead of Q4 Results | 2022-01-11 22:45:00 | <p>Analysts at RBC Capital provided their outlook on <a href='https://financialmodelingprep.com/financial-summary/UNM'>Unum Group (NYSE:UNM) </a>ahead of the company’s Q4 results, which are planned to be released on Feb 1.</p>
<p>The analysts made modest adjustments to their Q4 estimates (expected EPS of $0.94 vs. prior $0.99) to reflect expected Covid impacts. While claims severity may not be quite as high in Q4 vs. Q3, the company continues to be impacted by a younger average age from Covid deaths and ongoing short-term disability claims. </p>
| NYSE:UNM | https://financialmodelingprep.com/market-news/fmp-unum-group-outlook-ahead-of-q4-results | Davit Kirakosyan | Financial Modeling Prep |
|
Billionaire “Bond King” Advises Not to Buy Bitcoin at Current Prices | 2022-01-11 22:44:00 | <p>Jeffrey Gundlach, also known as the “Bond King”, who is the CEO of Doubleline Capital, which has over $137 billion in assets under management, did an interview with Yahoo Finance on Saturday, commenting on the risk of recession in 2022/2023.</p>
<p>Gundlach warned about a recession at the end of 2022, noting that the bond market is already showing enough signs of recession. Gundlach also commented on cryptos, advising investors not to buy it at current rates, adding that “maybe you should buy it at $25,000”.</p>
| BTCUSD | https://financialmodelingprep.com/market-news/fmp-billionaire-“bond-king”-advises-not-to-buy-bitcoin-at-current-prices | Davit Kirakosyan | Financial Modeling Prep |
|
Aptiv PLC to Acquire Wind River From TPG Capital for $4.3 Billion | 2022-01-11 17:29:00 | <p><a href='https://financialmodelingprep.com/financial-summary/APTV'>Aptiv PLC (NYSE:APTV) </a>made an announcement today, according to which it will acquire Wind River, an intelligent edge software provider for $4.3 billion from TPG Capital. The deal is expected to close in mid-2022.</p>
<p>This acquisition (Wind River expected to grow revenue from $400 million in 2021 to $1 billion by 2026), expands Aptiv’s smart vehicle platform software capability further down the stack to provide a real-time operating system and open-source middleware layer that enables faster software development and deployment time for features such as over-the-air connectivity and ADAS.</p>
| NYSE:APTV | https://financialmodelingprep.com/market-news/fmp-aptiv-plc-to-acquire-wind-river-from-tpg-capital-for-$43-billion | Davit Kirakosyan | Financial Modeling Prep |
|
Intel Has a New CFO | 2022-01-11 17:27:00 | <p><a href='https://financialmodelingprep.com/financial-summary/INTC'>Intel Corporation (NASDAQ:INTC) </a>announces the appointment of David Zinsner as the company’s CFO, effective January 17. Zinsner was the CFO of Micron, and also held CFO roles at Analog Devices and Intersil.</p>
<p>This decision was followed by the company’s announcement on its Q3 earnings call regarding current CFO George Davis' intentions to retire. George Davis will remain at the company in an advisory role until May 2022 to ensure a smooth transition.</p>
| NASDAQ:INTC | https://financialmodelingprep.com/market-news/fmp-intel-has-a-new-cfo | Davit Kirakosyan | Financial Modeling Prep |
|
Exelixis Reported Preliminary Q4 Results | 2022-01-11 17:25:00 | <p><a href='https://financialmodelingprep.com/financial-summary/EXEL'>Exelixis, Inc. (NASDAQ:EXEL) </a>announces its preliminary Q4 results, with Cabo franchise revenue coming in at around $300 million, beating the consensus estimate of $280 million. The company expects continued increases in cabo TRx's and NRx's for 1L RCC, which will likely remain as the company's main growth driver in 2022.</p>
<p>The company provided its full 2022-year product sales guidance of $1.325–1.425 billion from currently approved indications, in line with the company's goal to exit 2022 with a $1.5 billion annualized run-rate from RCC in the US. </p>
| NASDAQ:EXEL | https://financialmodelingprep.com/market-news/fmp-exelixis-reported-preliminary-q4-results | Davit Kirakosyan | Financial Modeling Prep |
|
Why Did Smartsheet Shares Drop 8%? | 2022-01-11 00:50:00 | <p><a href='https://financialmodelingprep.com/financial-summary/SMAR'>Smartsheet Inc. (NYSE:SMAR) </a>shares closed around 8% lower on Monday following the company’s virtual investor day, where management officially pushed out the timeframe to reach $1 billion revenue to 2024- 2025 from 2023-2035 prior.</p>
<p>Analysts at RBC Capital think that the negative market reaction is very surprising as the push-out was already implied, given management commentary on earnings calls. </p>
<p>Instead, the analysts believe that the Investor Day was solid, with the following key takeaways:</p>
<p>(1) 2025 targets of 30% growth and 10% FCF, </p>
<p>(2) positive data points on enterprise traction,</p>
<p>(3) encouraging proof points on capabilities-based product adoption.</p>
| NYSE:SMAR | https://financialmodelingprep.com/market-news/fmp-why-did-smartsheet-shares-drop-8? | Davit Kirakosyan | Financial Modeling Prep |
|
Omicron May Push Back Americold Realty Trust Recovery | 2022-01-11 00:48:00 | <p>Analysts at RBC Capital lowered their earnings estimates and price target on <a href='https://financialmodelingprep.com/financial-summary/COLD'>Americold Realty Trust (NYSE:COLD) </a>to $36 from $38 to reflect the increased risk that the omicron outbreak will further disrupt the food production recovery and push back the cold storage recovery by another 1-2 quarters. The analysts now expect economic occupancy to continue to decline on a year-on-year basis in the first half of 2022 before stabilizing during the second half, and do not expect occupancy will trend back to pre-COVID levels until 2023.</p> | NYSE:COLD | https://financialmodelingprep.com/market-news/fmp-omicron-may-push-back-americold-realty-trust-recovery- | Davit Kirakosyan | Financial Modeling Prep |
|
JPMorgan Says Applications From Crypto Have Only Just Started | 2022-01-11 00:46:00 | <p>Kenneth Worthington, an analyst at JPMorgan, published a report regarding the crypto outlook for 2022, viewing crypto markets as increasingly relevant to financial services.</p>
<p>According to the report, the applications from crypto have only just begun, with Web3.0, greater use of NFTs tokenization being in the visible horizon for 2022. It views tokenization and fractionalization as significantly promising given the crypto transactions speeds becoming more competitive with trad-fi networks.</p>
<p>While the analyst sees 2021 as the year of non-fungible tokens, he believes 2022 may be the year of financial tokenization.</p>
| BTCUSD | https://financialmodelingprep.com/market-news/fmp-jpmorgan-says-applications-from-crypto-have-only-just-started- | Davit Kirakosyan | Financial Modeling Prep |
|
Exact Sciences Corporation Pre-Announced Better-Than-Expected Q4 Revenue | 2022-01-10 16:05:00 | <p><a href='https://financialmodelingprep.com/financial-summary/EXAS'>Exact Sciences Corporation (NASDAQ:EXAS) </a>pre-announced Q4 revenue of $472–475 million, beating the consensus estimate of $441.6 million, with upside in each of the company's operating segments.</p>
<p>While being pleased with a rebound in the core Cologuard screening business following disappointing Q3 results, analysts at Oppenheimer said they are cautious of screening outlook for Q1/22. Given a 4-week lag between ordering and test completion, the analysts expect the full weight of disruption from the Omicron surge to be recognized in Q1/22. As a result, the analysts don’t expect screening business to return to stable growth until Q2/22 at the earliest.</p>
| NASDAQ:EXAS | https://financialmodelingprep.com/market-news/fmp-exact-sciences-corporation-pre-announced-better-than-expected-q4-revenue | Davit Kirakosyan | Financial Modeling Prep |
|
Atlassian Corporation’s Upside Expected in 2022/2023 | 2022-01-10 16:03:00 | Analysts at Oppenheimer provided their views on <a href='https://financialmodelingprep.com/financial-summary/TEAM'>Atlassian Corporation Plc (NASDAQ:TEAM)</a>, mentioning they are positive on the company and highlighting it as one of their top picks entering 2022. </p>
<p>According to the analysts, the key drivers behind strong performance and revenue upside in recent quarters remain intact, including </p>
<p>(1) strong subscription growth of above 40% year-over-year with broadening support as the company's cloud/SaaS transition shifts to larger organizations with more expansion power,</p>
<p>(2) ample opportunity in work management as it leverages a broad set of collaboration assets (Jira Work Management, Trello, Confluence, etc.) across multiple use cases.</p>
<p>(3) ongoing smooth execution across multiple vectors (customer additions, use case/product advancement, and effective customer engagement/price leverage). </p>
<p>The analysts believe the company is in an excellent position to continue to deliver upside in 2022/2023 and build cloud/SaaS momentum with larger customers.</p>
| NASDAQ:TEAM | https://financialmodelingprep.com/market-news/fmp-atlassian-corporation’s-upside-expected-in-20222023 | Davit Kirakosyan | Financial Modeling Prep |
|
fuboTV Shares Down 4% Despite Strong Preliminary Q4 Results | 2022-01-10 16:00:00 | <p><a href='https://financialmodelingprep.com/financial-summary/FUBO'>fuboTV Inc. (NYSE:FUBO) </a>shares were trading more than 4% lower Monday afternoon, despite the company’s reported strong Q4 preliminary revenue and subscribers results.</p>
<p>Preliminary quarterly revenue came in at $215-$220 million, in line with the Street estimates of $215 million, representing year-over-year growth of 107%. Subscribers grew 100% year-over-year to 1.1 million Q4, compared to the previous guidance of 1.065 million. This quarter marks the fifth consecutive quarter with a beat-and-raise, suggesting that the company is continuing to execute and manage its strategy and investor expectations.</p>
| NYSE:FUBO | https://financialmodelingprep.com/market-news/fmp-fubotv-shares-down-4-despite-strong-preliminary-q4-results | Davit Kirakosyan | Financial Modeling Prep |
|
Neurocrine Biosciences Shares Down 8% Following Q4 Ingrezza Revenue Miss | 2022-01-07 19:06:00 | <p><a href='https://financialmodelingprep.com/financial-summary/NBIX'>Neurocrine Biosciences, Inc. (NASDAQ:NBIX) </a>shares dropped more than 8% on Friday following the company’s reported preliminary Q4 Ingrezza net revenues, which came in at $301 million ($296 million + $5 million inventory), missing the $305 million consensus estimate. The results were driven by 56,400 unadjusted scripts representing 8% quarter-over-quarter volume growth.</p>
<p>Net pricing saw a slight decline to around $5,300 per script as rebates and discounts overcame the impact of a 4.5% list price increase in Dec 2021. Analysts at Oppenheimer believe this level of net pricing is relatively sustainable over the long term as the company has a solid track record of rational pricing. Analysts added they are encouraged by Ingrezza's volume driven growth despite continued COVID-19 headwinds and look forward to important catalysts in 2022, including sales guidance on Feb 11. </p
| NASDAQ:NBIX | https://financialmodelingprep.com/market-news/fmp-neurocrine-biosciences-shares-down-8-following-q4-ingrezza-revenue-miss | Davit Kirakosyan | Financial Modeling Prep |
|
Acuity Brands Reported Q1 Beat | 2022-01-07 19:02:00 | <p><a href='https://financialmodelingprep.com/financial-summary/AYI'>Acuity Brands, Inc. (NYSE:AYI) </a>reported Q1 results, with revenues coming in at $926 million (up 16.9%), beating the consensus estimate of $896 million. Adjusted EPS was $2.85, compared to the Street estimate of $2.41. Gross Margin was 41.7%, reflecting volume, continuous product and productivity improvements, and price, largely offsetting significantly higher materials and freight costs. </p> | NYSE:AYI | https://financialmodelingprep.com/market-news/fmp-acuity-brands-reported-q1-beat | Davit Kirakosyan | Financial Modeling Prep |
|
Google Trends Show Interest in Bitcoin Has Dropped | 2022-01-07 19:01:00 | <p>According to Google Trends, interest in Bitcoin, which skyrocketed in May 2021, has dropped significantly since then. Currently, Bitcoin has a score of 28 on Google Trends, which is 72% lower than the highest score of 100, which was achieved in the week of May 16th through the 22nd.</p> | BTCUSD | https://financialmodelingprep.com/market-news/fmp-google-trends-show-interest-in-bitcoin-has-dropped | Davit Kirakosyan | Financial Modeling Prep |
|
Berkeley Lights Shares Dropped 40% on CEO Transition & Reduced 2021 Revenue Announcements | 2022-01-07 13:21:00 | <p><a href='https://financialmodelingprep.com/financial-summary/BLI'>Berkeley Lights, Inc. (NASDAQ:BLI) </a>shares dropped almost 40% on Thursday following the company’s announcements, according to which its CEO Eric Hobbs would be transitioning from his CEO position to become the president of the company’s Antibody Therapeutics segment, and the preliminary revenues for 2021 are estimated to be $84-$84.5 million (up 30% year-over-year).</p>
<p>Dr. Hobbs will remain in his current position of CEO until a successor is appointed.</p>
<p>The company’s 2021 revenue estimates represent around 8% reduction from the prior guidance in November when the company estimated revenues in the low $90 million range.</p>
<p>The company also updated its full 2022-year outlook, expecting a 30% revenue growth, which implies revenues of $109.5 million.</p>
| NASDAQ:BLI | https://financialmodelingprep.com/market-news/fmp-berkeley-lights-shares-dropped-40-on-ceo-transition-&-reduced-2021-revenue-announcements | Davit Kirakosyan | Financial Modeling Prep |
|
Key Highlights From Duck Creek Technologies’ Q1 Results | 2022-01-07 13:18:00 | <p><a href='https://financialmodelingprep.com/financial-summary/DCT'>Duck Creek Technologies, Inc. (NASDAQ:DCT) </a>reported solid Q1 results, with the total revenue coming in at $73.4 million, representing a 25% increase compared to the same period the previous year, and beating the consensus estimate of $68.9 million. </p>
<p>Analysts at RBC Capital provided the following key highlights from Q1:</p>
<p>(1) strong services revenue helped to drive outperformance while subscription revenue decelerated 7 points,</p>
<p>(2) New deal commentary was positive, with multiple T1 deals expected in the second half of the year,</p>
<p>(3) SaaS ARR growth decelerated 2 points but was strong on a dollar basis.</p>
<p>The analysts decreased their price target on the company’s shares to $38 from $47, while maintaining their outperform rating.</p>
| NASDAQ:DCT | https://financialmodelingprep.com/market-news/fmp-key-highlights-from-duck-creek-technologies’-q1-results | Davit Kirakosyan | Financial Modeling Prep |
|
Personalis Shares Up 8% on Q4 Results | 2022-01-07 13:14:00 | <p><a href='https://financialmodelingprep.com/financial-summary/PSNL'>Personalis, Inc. (NASDAQ:PSNL) </a>shares were trading more than 8% higher Friday afternoon, following the company’s pre-announced Q4 results, with revenue coming in $20.7 million, compared to the consensus estimate of $20.3 million, driven by stronger-than-expected non-VA revenue.</p>
<p>The company maintained its target of over 50% growth in non-VA revenue in 2022 as orders during Q4 once again exceeded recognized non-VA revenue. The company disclosed revenue contribution from its collaboration with Natera for the first time. This figure came in at $5.8 million in Q4 and $9.6 million for the full 2021-year.</p>
| NASDAQ:PSNL | https://financialmodelingprep.com/market-news/fmp-personalis-shares-up-8-on-q4-results | Davit Kirakosyan | Financial Modeling Prep |
|
MongoDB 2022 Bullish Outlook By Oppenheimer | 2022-01-06 22:34:00 | <p>Analysts at Oppenheimer provided their outlook on <a href='https://financialmodelingprep.com/financial-summary/MDB'>MongoDB, Inc. (NASDAQ:MDB)</a>, which saw its stock price decline around 18% since the start of this year. The analysts mentioned the following key points that back their bullish thesis on the company:</p>
<p>(1) Atlas is expected to remain the main focal point for investors this year, with the company believed to sustain its strong Atlas momentum of 84.4% year-over-year revenue growth in Q3, as more customers shift to DBaaS deployments.</p>
<p>(2) Concerns around AWS's database solutions are overdone and the brokerage views AWS as more of a balanced partner rather than a competitor.</p>
<p>(3) Consistent growth in the Enterprise Advance business of 19.6% year-over-year in Q3.</p>
<p>(4) The brokerage expects the company to continue to be aggressive with investments in S&M/R&D.</p>
| NASDAQ:MDB | https://financialmodelingprep.com/market-news/fmp-mongodb-2022-bullish-outlook-by-oppenheimer | Davit Kirakosyan | Financial Modeling Prep |
|
Biohaven Pharmaceutical Pre-Announced Q4 Beat, Shares Up 5% | 2022-01-06 22:31:00 | <p><a href='https://financialmodelingprep.com/financial-summary/BHVN'>Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) </a>shares closed more than 5% higher on Thursday following the company’s pre-announcement, according to which its Q4 Nurtec ODT end-user revenue came in at $190 million (up 48% quarter-over-quarter), beating the consensus estimate of $140 million. The company mentioned no material inventory level changes, suggesting strong organic growth. </p>
<p>Analysts at Wedbush continue to see the dual prevention/treatment label as a key differentiation point for Nurtec ODT, and raised their price target on the company’s shares to $149 from $144 following the pre-announcement. </p>
| NYSE:BHVN | https://financialmodelingprep.com/market-news/fmp-biohaven-pharmaceutical-pre-announced-q4-beat-shares-up-5 | Davit Kirakosyan | Financial Modeling Prep |
|
Goldman Sachs Says Bitcoin Could Reach $100,000 | 2022-01-06 22:28:00 | <p>Goldman Sachs analyst Zach Pandl, provided his outlook for bitcoin in a research note to clients, stating that he believes Bitcoin will take more market share away from gold, as a store of value. </p>
<p>According to the analyst, Bitcoin, with its current float-adjusted market capitalization under $700 billion, accounts for a 20% share of the “store of value” market. The total of this market, comprised of gold and bitcoin, is worth around $2.6 trillion, and if bitcoin’s share continues to rise, for example, up to 50% over the next five years, the price would increase to around $100,000 and more.</p>
| BTCUSD | https://financialmodelingprep.com/market-news/fmp-goldman-sachs-says-bitcoin-could-reach-$100000- | Davit Kirakosyan | Financial Modeling Prep |
|
Turtle Beach Corporation Pre-Announces 2021 Revenues | 2022-01-06 14:41:00 | <p><a href='https://financialmodelingprep.com/financial-summary/HEAR'>Turtle Beach Corporation (NASDAQ:HEAR) </a>updated selected financials based on preliminary unaudited information, expecting a revenue of $365 million for the full 2021-year, compared to its prior guidance of $365-380 million. This implies revenue of $108 million (down 19% year-over-year) for Q4/21.</p>
<p>Analysts at Oppenheimer said they remain confident in the company’s ability to handle its own supply chain issues and expand non-headphone categories, representing around 20% of the company’s total revenues, however, noting that near-term industry headwinds such as underperforming AAA games and console shortages push them to lower their near-term growth outlook. The analysts decreased their price target on the company’s shares to $34 from $41, while maintaining their outperform rating.</p>
<p>Oppenheimer now expects full 2021-year revenue/adjusted EBITDA of $365 million/$36 million, compared to its prior estimates of $373 million/$40 million. The brokerage also lowered its 2022 estimates to $382 million/$44 million from $420 million/ $51 million, due to near-term revenue headwinds that may extend to H1/22.</p>
| NASDAQ:HEAR | https://financialmodelingprep.com/market-news/fmp-turtle-beach-corporation-pre-announces-2021-revenues | Davit Kirakosyan | Financial Modeling Prep |
|
Marvell Technology, Inc. Review by Deutsche Bank | 2022-01-06 14:38:00 | Analysts at Deutsche Bank provided their views on <a href='https://financialmodelingprep.com/financial-summary/MRVL'>Marvell Technology, Inc. (NASDAQ:MRVL) </a>following CES 2022. While the larger than usual and impressive revenue beat in the recent two quarters was in part the result of improving supply conditions, the company mentioned that this improvement was due to long-term strategic changes in supply chain management that has been ongoing for the majority of 2021, rather than a sudden occurrence. </p>
<p>The company’s management mentioned that its strong, sustainable, and long-term growth profile enables the company to position itself as an attractive customer to the supplier base, giving it the confidence to sign long-term supply agreements that provide the company with the ability to deliver significant revenue growth. Management reiterated its 30% growth target for 2023.</p>
| NASDAQ:MRVL | https://financialmodelingprep.com/market-news/fmp-marvell-technology-inc-review-by-deutsche-bank | Davit Kirakosyan | Financial Modeling Prep |
|
The Simply Good Foods Company Reported Q1 Beat | 2022-01-06 14:35:00 | <p><a href='https://financialmodelingprep.com/financial-summary/SMPL'>The Simply Good Foods Company (NASDAQ:SMPL) </a>provided its Q1 results, with adjusted EPS coming in at $0.43, beating the consensus estimate of $0.34. Quarterly revenue increased by 22% to $281.3 million, compared to the consensus estimate of $266 million.</p>
<p>While cost challenges will likely remain acute in 2022 (the company’s gross margin outlook was disappointing), analysts at Deutsche Bank said they are encouraged by top-line and demand/elasticity dynamics, and like the management's confidence in returning gross margins to above 40% in 2023, whether enabled by eventual cost relief and/or another round of incremental pricing exiting 2022. </p>
| NASDAQ:SMPL | https://financialmodelingprep.com/market-news/fmp-the-simply-good-foods-company-reported-q1-beat | Davit Kirakosyan | Financial Modeling Prep |
|
SMART Global Holdings Shares Down 15%, Reports Strong Q1 Results | 2022-01-06 00:10:00 | <p><a href='https://financialmodelingprep.com/financial-summary/SGH'>SMART Global Holdings, Inc. (NASDAQ:SGH) </a>shares closed more than 15% lower on Wednesday despite the company’s reported strong Q1 results, with EPS coming in at $2.16, beating the consensus estimate of $1.99. The upside was driven by strong demand for Intelligent Platform Solutions. </p>
<p>According to the analysts from Deutsche Bank, the company is making good progress in transforming the LED business, expanding the IPS opportunity particularly on the commercial side, and addressing new opportunities (SSD and data centers) in Memory Solutions. </p>
<p>The possible reason for the stock decline may be the investors’ overreaction to the company’s announcement regarding the stock split and revenue outlook.</p>
| NASDAQ:SGH | https://financialmodelingprep.com/market-news/fmp-smart-global-holdings-shares-down-15-reports-strong-q1-results | Davit Kirakosyan | Financial Modeling Prep |
|
iCAD, Inc. Reported Preliminary Q4 Revenue Missed The Estimates | 2022-01-06 00:08:00 | <p><a href='https://financialmodelingprep.com/financial-summary/ICAD'>iCAD, Inc. (NASDAQ:ICAD) </a>reported its preliminary Q4 results, with sales coming in at $7.8–8.0 million, missing the Street estimate of $10.7 million. According to the company, the disruptions in quarterly revenue were primarily because of the surge of Omicron in December leading to clinical and administrative staffing shortages. </p>
<p>Despite the negative preliminary results, the analysts at Oppenheimer mentioned that they are encouraged by the company's decision to gradually implement a subscription sales model starting in Q1/22 and re-organize its sales functions. </p> | NASDAQ:ICAD | https://financialmodelingprep.com/market-news/fmp-icad-inc-reported-preliminary-q4-revenue-missed-the-estimates | Davit Kirakosyan | Financial Modeling Prep |
|
Wharton's Professor Predict More Fed Hikes. Bitcoin Is a New Gold For Millennials | 2022-01-06 00:06:00 | <p>Jeremy Siegel, a finance professor at Wharton School, University of Pennsylvania, shared his views on bitcoin and inflation during an interview with CNBC last week. Siegel warned about the inflation, mentioning that Fed will hike more than what the market anticipates.</p>
<p>Stating that gold has been disappointing, he noted that Bitcoin is seen as a replacement for gold for millennials, who view it as a good inflation hedge. </p>
| BTCUSD | https://financialmodelingprep.com/market-news/fmp-whartons-professor-predict-more-fed-hikes-bitcoin-is-a-new-gold-for-millennials | Davit Kirakosyan | Financial Modeling Prep |
|
What to Expect From Walgreens Boots Alliance’s Q1 Results? | 2022-01-05 15:03:00 | <p><a href='https://financialmodelingprep.com/financial-summary/WBA'>Walgreens Boots Alliance, Inc. (NASDAQ:WBA) </a>will report its Q1 results tomorrow. Analysts at Deutsche Bank provided their outlook on the company ahead of the results, expecting the company to handily beat the Street estimates as it remains well-positioned to respond to the challenge of the COVID crisis. </p>
<p>The analysts expect quarterly revenue to decline 9% year-over-year to $33.1 billion, and EPS to come in at $1.38, better than the consensus estimate of $1.34.</p>
| NASDAQ:WBA | https://financialmodelingprep.com/market-news/fmp-what-to-expect-from-walgreens-boots-alliance’s-q1-results? | Davit Kirakosyan | Financial Modeling Prep |
|
bluebird bio Has Major Hurdles Ahead and Limited Upside to the Stock | 2022-01-05 15:02:00 | Analysts at Berenberg Bank provided their views on <a href='https://financialmodelingprep.com/financial-summary/BLUE'>bluebird bio, Inc. (NASDAQ:BLUE)</a>, which saw its stock decline more than 60% in the last 12 months, stating that they see significant hurdles ahead and limited upside to the stock, despite the company intending to bring three products to the U.S. market in the next two years. </p>
<p>Despite two BLA submissions for bluebird bio’s lead programs (eli-cel and beti-cel) having been completed, the analysts remain cautious regarding their approval and commercial prospects. While eli-cel is already approved in the EU, the company is still working to lift the clinical hold that the U.S. FDA placed in mid-2021 and awaits a potential approval in mid- 2022. While Beti-cel will likely become the first gene therapy for this indication approved in the U.S., the analysts believe regulatory uncertainties persist.</p>
<p>The brokerage views the sales potential of these two products, even if they are approved, as particularly limited.</p>
| NASDAQ:BLUE | https://financialmodelingprep.com/market-news/fmp-bluebird-bio-has-major-hurdles-ahead-and-limited-upside-to-the-stock | Davit Kirakosyan | Financial Modeling Prep |
|
Realogy Holdings Reported Preliminary Q4 Results; Announces New Senior Notes Offering | 2022-01-05 14:59:00 | <p><a href='https://financialmodelingprep.com/financial-summary/RLGY'>Realogy Holdings Corp. (NYSE:RLGY) </a>reported its preliminary Q421 results and announces new senior notes offering.</p>
<p>Analysts at Berenberg Bank provided their views on the company, stating they view the preliminary results as positive regarding the gross transaction volume, while also noting that the final results could be different. </p>
<p>On a combined basis (RFG + RBG), the company’s Q4 transaction volume was up 3% year-over-year and 2021 transaction volume was up 29% year-over-year. </p>
<p>The company announced a $550 million senior notes offering, which is also viewed as a positive as it highlights the company’s commitment to strengthening its balance sheet. The new notes will be subordinated to all of the company’s existing debt and the company intends to use the proceeds to redeem its $550 million 9.375% senior notes. With the current level of low-interest rates, the analysts expect the rate on the new notes to be significantly lower.</p>
| NYSE:RLGY | https://financialmodelingprep.com/market-news/fmp-realogy-holdings-reported-preliminary-q4-results;-announces-new-senior-notes-offering | Davit Kirakosyan | Financial Modeling Prep |
|
What to Expect From Franklin Covey’s Q1 Results? | 2022-01-04 21:58:00 | <p>Analysts at Barrington Research provided their outlook on <a href='https://financialmodelingprep.com/financial-summary/FC'>Franklin Covey Co. (NYSE:FC)</a> ahead of the company’s Q1 results, expected to be reported on January 6. The analysts anticipate the quarterly revenue to grow 11.7% and come in at $54 million, with adjusted EBITDA of $6.2 million (up 67.8% year-over-year) and diluted EPS of $0.03. </p>
<p>The analysts provided their outlook for the full 2022-year also, expecting revenue of $250 million (up 11.5% year-over-year), adjusted EBITDA of $35 million (up 25.2% year-over-year), and diluted EPS of $0.62.</p>
| NYSE:FC | https://financialmodelingprep.com/market-news/fmp-what-to-expect-from-franklin-covey’s-q1-results? | Davit Kirakosyan | Financial Modeling Prep |
|
Nexo Founder Expects Bitcoin to Reach $100,000 By Mid-2022 | 2022-01-04 21:56:00 | <p>Antoni Trenchev, the co-founder and managing partner of Nexo, a cryptocurrency lender with more than $6 billion issued credits and more than 2.5 million users globally, provided his views on Bitcoin during an interview with CNBC yesterday.</p>
<p>Trenchev anticipated the price of Bitcoin to reach $100,000 by mid-2022, providing two main reasons for his bullish view: (1) The institutions add more bitcoin in their corporate treasuries, and (2) with more FED hikes expected this year, “cheap money” is going to stay and thus drive the crypto prices higher.</p>
| BTCUSD | https://financialmodelingprep.com/market-news/fmp-nexo-founder-expects-bitcoin-to-reach-$100000-by-mid-2022 | Davit Kirakosyan | Financial Modeling Prep |
|
Exelon Corporation Price Target Raised at RBC Capital | 2022-01-04 19:02:00 | <p>According to RBC Capital analysts, the separation of Constellation Energy from <a href='https://financialmodelingprep.com/financial-summary/EXC'>Exelon Corporation (NASDAQ:EXC) </a>is quickly approaching. The analysts believe that the key ingredient that could drive the combined stock price higher is the passage of the $1.85 trillion Build Back Better (BBB) Act, in particular the introduction of nuclear production tax credits (PTCs).</p>
<p>The analysts raised their price target on the company to $60 from $51, assuming a 33% probability of supportive PTCs.</p>
| NASDAQ:EXC | https://financialmodelingprep.com/market-news/fmp-exelon-corporation-price-target-raised-at-rbc-capital | Davit Kirakosyan | Financial Modeling Prep |
|
The Estée Lauder Companies is Well Positioned For 2022 | 2022-01-04 18:59:00 | <p><a href='https://financialmodelingprep.com/financial-summary/EL'>The Estée Lauder Companies Inc. (NYSE:EL) </a>shares grew around 40% last year, outperforming around 27% gain in the S&P 500. Analysts at Oppenheimer provided their views on the company, re-evaluating the upside case over the next 12-18 months and increasing their price target to $410 from $355.</p>
<p>The analysts believe the company remains uniquely positioned within CPG land to deliver attractive levels of both top and bottom-line expansion in a historically growth-challenged CPG universe, adding that Beauty remains their top vertical entering 2022 and they see continued recovery potential as consumer behavior gradually normalizes. </p>
| NYSE:EL | https://financialmodelingprep.com/market-news/fmp-the-estée-lauder-companies-is-well-positioned-for-2022 | Davit Kirakosyan | Financial Modeling Prep |
|
Okta Review By Oppenheimer | 2022-01-04 18:55:00 | <p>Analysts at Oppenheimer presented their outlook on <a href='https://financialmodelingprep.com/financial-summary/OKTA'>Okta, Inc. (NASDAQ:OKTA)</a>, stating that the Secure Customer Identity and Access Management (CIAM) share gain opportunity in 2022 is underappreciated.</p>
<p>Contrary to investor concerns, the analysts believe the company’s core remains strong, and can sustain over 30% revenue growth longer-term. Among the catalysts driving an above consensus 2022 growth, the brokerage mentioned: (1) higher cross-sell between Auth0/Okta customers; (2) strong CIAM competitive positioning, and (3) an opportunity to sell the company's IGA/PAM products with a now unified salesforce.</p>
| NASDAQ:OKTA | https://financialmodelingprep.com/market-news/fmp-okta-review-by-oppenheimer- | Davit Kirakosyan | Financial Modeling Prep |
|
Citizens Financial Group Is Well Positioned For 2022 | 2022-01-03 21:31:00 | <p>Analysts at Wedbush provided their views on <a href='https://financialmodelingprep.com/financial-summary/CFG'>Citizens Financial Group, Inc. (NYSE:CFG)</a>, stating they believe the company is better positioned to generate positive operating leverage in 2022 in comparison to most of its peers.</p>
<p>Between the acquisition of HSBC's 80 East Coast branches and national digital deposit franchise closing in Q1 (expected to add around 800,000 new consumers) and Investors Bancorp acquisition expected to close in Q2/22 (expected to add around 200,000 customers), the company will set the stage for substantial cross-sell revenues opportunities to a customer base that has essentially been underserved. </p>
<p>The company is expanding into new higher growth contiguous markets, which should lead to improved household growth and better customer retention.</p>
| NYSE:CFG | https://financialmodelingprep.com/market-news/fmp-citizens-financial-group-is-well-positioned-for-2022-- | Davit Kirakosyan | Financial Modeling Prep |
|
NeuBase’s Potential For Clinical Candidate 2022 | 2022-01-03 21:28:00 | <p>Analysts at Oppenheimer provided their outlook on <a href='https://financialmodelingprep.com/financial-summary/NBSE'>NeuBase Therapeutics, Inc. (NASDAQ:NBSE) </a>following Q4 results announcement and their virtual call with the management.</p>
<p>The company recently nominated the development candidate for its lead, NT0200 program in Myotonic Dystophy 1 (DM1) and started CMC scale-up to support IND-enabling studies and multi-dose Phase 1/2 clinical trials.</p>
<p>According to the brokerage further preclinical data updates are expected in 2022 in Huntington's Disease (HD) program. The company is also advancing its oncology program targeting KRAS G12D/ G12V mutations to in vivo pharmacology studies. </p>
<p>The brokerage maintained its bullish view given the company’s transformation from a research-stage to a development-stage company and the lead candidate poised to enter the clinic in 2022.</p>
| NASDAQ:NBSE | https://financialmodelingprep.com/market-news/fmp-neubase’s-potential-for-clinical-candidate-2022 | Davit Kirakosyan | Financial Modeling Prep |
|
Tesla Stock is Up 10% on Impressive Q4 Deliveries | 2022-01-03 13:07:00 | <p><a href='https://financialmodelingprep.com/financial-summary/TSLA'>Tesla, Inc. (NASDAQ:TSLA) </a>shares were trading more than 10% higher Monday morning following the company’s reported Q4 deliveries, which were substantially higher than the Street expectations. The company’s quarterly deliveries were 308,600 units, compared to the consensus estimate of 265,000 units. </p>
<p>Total production in Q4 was 305,840 units, which is impressive given the chip shortage being a major overhang on the auto industry and the issues of global logistical. The company continues to cope with the semis shortages better than the rest of the companies in the auto space.</p>
| NASDAQ:TSLA | https://financialmodelingprep.com/market-news/fmp-tesla-stock-is-up-10-on-impressive-q4-deliveries- | Davit Kirakosyan | Financial Modeling Prep |
|
Coinbase Global Q4 Preview, Record Trading Volume Expected | 2022-01-03 13:04:00 | <p>Analysts at Oppenheimer provided their views on <a href='https://financialmodelingprep.com/financial-summary/COIN'>Coinbase Global, Inc. (NASDAQ:COIN)</a>, estimating the company’s Q4 trading volume to reach $540 billion (17% above the consensus) as the volatility in Bitcoin and other cryptos during the quarter drove high trading volumes. </p>
<p>Given the record trading volume expectations, 13% above consensus revenue, and potential fee rate expansion, the analysts increase their Q4 revenue estimate to $2.1 Billion from $1.9 billion, with an EPS estimate of $2.12.</p>
| NASDAQ:COIN | https://financialmodelingprep.com/market-news/fmp-coinbase-global-q4-preview-record-trading-volume-expected | Davit Kirakosyan | Financial Modeling Prep |
|
Bed Bath & Beyond Shares Up 5% Despite Expected Q3 Miss | 2022-01-03 13:01:00 | <p><a href='https://financialmodelingprep.com/financial-summary/BBBY'>Bed Bath & Beyond Inc. (NASDAQ:BBBY) </a>shares were trading around 5% higher Monday morning, despite the analysts expecting the company to post a Q3 miss on Jan 6.</p>
<p>Analysts at Wedbush provided their views on the company ahead of the quarterly results, stating they see limited drivers of upside on the print, anticipating a miss on both revenues and EPS.</p>
<p>The analysts believe that the number of negatives with signs of additional market share losses, will probably not be offset by growth opportunities in Baby items and marketplaces as well as more aggressive share repurchases potential.</p>
<p>While the company’s merchandising transformation has the potential to drive stronger unit sales at higher margins, the analysts are cautious, as they have seen limited signs of this paying off in 2021.</p>
| NASDAQ:BBBY | https://financialmodelingprep.com/market-news/fmp-bed-bath-&-beyond-shares-up-5-despite-expected-q3-miss | Davit Kirakosyan | Financial Modeling Prep |
|
Biogen May Be a Target For Acquisition at Around $42 Billion Valuation | 2021-12-31 19:57:00 | <p>Analysts at Oppenheimer provided their views on <a href='https://financialmodelingprep.com/financial-summary/BIIB'>Biogen Inc. (NASDAQ:BIIB) </a>stating that the company appears to be in play as a potential acquisition target based on Thursday news mentioning the possibility of the company to be taken out in a deal valued at around $42 billion. </p>
<p>While the analysts take no view on the likelihood of an alleged deal, it would represent only around 20% premium over the 30- day average price, which would be relatively low compared to other deals. Biotech acquisition premiums have steadily increased since a relative low point in 2017.</p> | NASDAQ:BIIB | https://financialmodelingprep.com/market-news/fmp-biogen-may-be-a-target-for-acquisition-at-around-$42-billion-valuation | Davit Kirakosyan | Financial Modeling Prep |
|
Ignore Bitcoin Deniers | 2021-12-31 19:55:00 | <p>While Bitcoin dropped more than 18% in December, recording its worst monthly performance since May 2021, Nigel Green from deVere Group advises to “ignore the crypto deniers”, whose arguments focused on two main things - (1) cryptocurrencies are used by criminals, (2) crypto market is volatile, “have been answered”.</p>
<p>Instead, Green suggests investors, who want to build their wealth for the long-term, should look at the data, which shows that Bitcoin has outperformed both stocks and gold for the third consecutive year.</p>
| BTCUSD | https://financialmodelingprep.com/market-news/fmp-ignore-bitcoin-deniers | Davit Kirakosyan | Financial Modeling Prep |
|
Xeris Biopharma Holdings Shares Soared 26% on Recorlev FDA Approval | 2021-12-31 12:29:00 | <p><a href='https://financialmodelingprep.com/financial-summary/XERS'>Xeris Biopharma Holdings, Inc. (Nasdaq:XERS) </a>shares soared more than 26% yesterday driven by the company’s announcement regarding the U.S. Food and Drug Administration (FDA) approval of its Recorlev® (levoketoconazole). </p><p>According to the announcement, Recorlev®, which is used for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s Syndrome, was approved by FDA, making it a safe and effective therapeutic option for patients for whom surgery is not an option or has not been curative.</p> | Nasdaq:, XERS | https://financialmodelingprep.com/market-news/fmp-xeris-biopharma-holdings-shares-soared-26-on-recorlev-fda-approval | Davit Kirakosyan | Financial Modeling Prep |
|
AMD and Xilinx Announce A Delay in The Closure of Acquisition Transaction | 2021-12-31 12:27:00 | <p><a href='https://financialmodelingprep.com/financial-summary/AMD'>AMD (NASDAQ: AMD) </a>and <a href='https://financialmodelingprep.com/financial-summary/XLNX'>Xilinx, Inc. (NASDAQ: XLNX) </a>released an update yesterday regarding the timing of the closure of AMD’s proposed acquisition of Xilinx. According to the announcement, there is good progress on regulatory approval for the transaction, however, now the companies estimate the deal to close in Q1/2022. Previously, it was estimated that all regulatory approvals will be finished by the end of this year. The companies noted that there will be no additional changes to the terms announced previously.</p> | NASDAQ:AMD | https://financialmodelingprep.com/market-news/fmp-amd-and-xilinx-announce-a-delay-in-the-closure-of-acquisition-transaction | Davit Kirakosyan | Financial Modeling Prep |
|
FuelCell Energy Missed Q4 Results, Announces 2022 Growth Investment Plans | 2021-12-30 23:15:00 | <p><a href='https://financialmodelingprep.com/financial-summary/FCEL'>FuelCell Energy, Inc. (NASDAQ:FCEL) </a>released its Q4 results, with EPS coming in at ($0.07), worse than the consensus estimate of ($0.02). </p>
<p>With the POSCO settlement now in the company's rearview, and a $460.2 million liquidity position, the company announced investment plans in order to tap the large and growing market opportunity for its technology systems. The company is planning $40-50 million in capex spending in 2022 on its factories for carbonate and solid oxide production capacity, compared to $6.4 million spent in 2021. In addition, the company plans to spend $45-55 million for the acceleration of the commercialization of its Advanced Technologies solutions.</p>
<p>Analysts at Oppenheimer view this announcement as indicative of the company's focus shifting back to that of a technology-focused growth company.</p>
| NASDAQ:FCEL | https://financialmodelingprep.com/market-news/fmp-fuelcell-energy-missed-q4-results-announces-2022-growth-investment-plans | Davit Kirakosyan | Financial Modeling Prep |
|
Elon Musk Says Dogecoin is Better Than Anything Else | 2021-12-30 23:12:00 | <p>Elon Musk, the CEO of Tesla, shared his views on crypto during an interview with Lex Fridman on Tuesday, praising Dogecoin and comparing it to Bitcoin. While Dogecoin started as a joke, it’s actually valuable as per Musk, because it has a much higher transaction volume capability than bitcoin and a very low cost of transaction. He continued with criticizing Bitcoin, highlighting the high cost of transaction.</p> | DOGEUSD | https://financialmodelingprep.com/market-news/fmp-elon-musk-says-dogecoin-is-better-than-anything-else- | Davit Kirakosyan | Financial Modeling Prep |
|
DiDi Global Shares Dropped Following Interim Unaudited Results Announcement | 2021-12-30 11:23:00 | <p><a href='https://financialmodelingprep.com/financial-summary/DIDI'>DiDi Global Inc. (NYSE: DIDI) </a>released its unaudited interim condensed financial results for Q2/21 and Q3/21. Q3 revenue came in at RMB 42.7 billion (or $6.6 billion). China Mobility segment revenue was RMB 39.0 billion (or $6.1 billion), while the International segment revenue was RMB 1.0 billion (or $0.1 billion). The company’s Q2 revenue came in at RMB 48,212, versus RMB 31,167 for the same period last year.</p>
<p>The company’s shares dropped more than 8% yesterday following the announcement. The stock is down more than 30% in December.</p>
| NYSE:, DIDI | https://financialmodelingprep.com/market-news/fmp-didi-global-shares-dropped-following-interim-unaudited-results-announcement | Davit Kirakosyan | Financial Modeling Prep |
|
Jana Partners Wants a Different Scenario For Encompass Health Corporation | 2021-12-30 11:21:00 | <p>Activist investment firm Jana Partners is planning to push <a href='https://financialmodelingprep.com/financial-summary/EHC'>Encompass Health Corporation (NYSE:EHC) </a>to re-engage with interested third parties on a merger for the company’s home health and hospice business before moving forward with a plan of separating it into an independent public company via a carve-out IPO, spin-off, or split-off.</p>
<p>Jana Partners, which is rumored to have teamed up with health care industry executive Edwin "Mac" Crawford in order to make the company implement this change, believes there is interest from private firms to combine with the home health and hospice business of the company and this is believed to help the company manage challenging conditions in the healthcare industry, including a shortage of nurses.</p>
<p>The company’s share price has declined around 20% since the start of the year.</p>
| NYSE:EHC | https://financialmodelingprep.com/market-news/fmp-jana-partners-wants-a-different-scenario-for-encompass-health-corporation | Davit Kirakosyan | Financial Modeling Prep |
|
It’s a Mistake to Ignore Crypto. Blueprint Capital Advisors CEO Expects Crypto to Outperform Equities | 2021-12-30 11:18:00 | <p>Jacob Walthour, the CEO of Blueprint Capital Advisors, shares his outlook on cryptos and equities. Noting that many companies currently accept crypto as a form of payment, Walthour warns that it is a mistake to ignore this asset class, expecting crypto to outperform equities in the near future. He also anticipates a lot of liquidity to fall out of equities into crypto.</p>
| BTCUSD | https://financialmodelingprep.com/market-news/fmp-it’s-a-mistake-to-ignore-crypto-blueprint-capital-advisors-ceo-expects-crypto-to-outperform-equities | Davit Kirakosyan | Financial Modeling Prep |
|
CURO Group Shares Down 5% on Disappointing Q4 Guidance | 2021-12-29 21:22:00 | <p><a href='https://financialmodelingprep.com/financial-summary/CURO'>CURO Group Holdings Corp. (NYSE:CURO) </a>shares closed more than 5% lower on Wednesday. The company’s management issued a new investor presentation with a Q4/21 guidance that appears to be disappointing to many investors.</p>
<p>The company expects Q4 adjusted EPS to be between ($0.37)-($0.34), which is below the consensus estimate of ($0.01). The management estimates quarterly revenue to be over $220 million, with net revenue of over $124 million.</p>
<p>The company also announced the closing of its planned acquisition of Heights Finance. </p>
| NYSE:CURO | https://financialmodelingprep.com/market-news/fmp-curo-group-shares-down-5-on-disappointing-q4-guidance | Davit Kirakosyan | Financial Modeling Prep |
|
Billionaire Ray Dalio Says There is a Limit to Bitcoin Price | 2021-12-29 21:20:00 | <p>Ray Dalio, the founder of the world’s largest hedge fund, Bridgewater Associates, shared his thoughts on Bitcoin in a recent interview. When being asked about the possibility of Bitcoin price hitting $1 million, which some investors estimate now, Dalio responded with a short “I don’t think that’s possible”.</p>
<p>He said he believes the price of bitcoin could not reach a very high number, stating a comparison between Bitcoin and Gold. There are certain amounts of both of these two assets, with $5 trillion worth of Gold in the market that is not being used for jewelry purposes or used by central banks, and around 2 trillion crypto market. And as he doesn’t believe that Bitcoin will be worth more than Gold, there is no possibility the crypto market could grow to the extremely high numbers that some investors anticipate.</p> | BTCUSD | https://financialmodelingprep.com/market-news/fmp-billionaire-ray-dalio-says-there-is-a-limit-to-bitcoin-price | Davit Kirakosyan | Financial Modeling Prep |
|
Huntsman Corporation Shares Up 4% Following Two Major Initiatives Announcement | 2021-12-29 10:55:00 | <p><a href='https://financialmodelingprep.com/financial-summary/HUN'>Huntsman Corporation (NYSE:HUN) </a>shares were trading almost 4% higher Wednesday morning following the company’s two announcements yesterday. </p>
<p>First, the company’s Board of Directors has authorized the management team to implement a strategic review (expected to begin in Q1/22) of the company’s Textile Effects Division, including a potential sale. </p>
<p>Second, a multi-year compensation plan (equity incentives linked to relative Total Shareholder Return and Free Cash Flow measures; incentive cash bonus program connected to the achievement of the Adjusted EBITDA margin, Optimization Program and Free Cash Flow targets) is to be designed connected to the company’s financial targets laid out at Investor Day in November.</p>
| NYSE:HUN | https://financialmodelingprep.com/market-news/fmp-huntsman-corporation-shares-up-4-following-two-major-initiatives-announcement | Davit Kirakosyan | Financial Modeling Prep |
|
Expro Group Holdings’ 2022 Outlook | 2021-12-29 10:53:00 | <p>Analysts at Tudor, Pickering, Holt & Co. provided their outlook on <a href='https://financialmodelingprep.com/financial-summary/XPRO'>Expro Group Holdings N.V. (NYSE:XPRO) </a>for 2022. Despite the company’s recent struggles, the analysts expect Expro Group Holdings’ top-line growth to remain relatively subdued in the near term as typical seasonal factors take their toll (e.g., N Hemisphere weather, NOCs oftentimes ramping up through Q1, etc.) and COVID-19 related mobility restrictions persist. Moreover, the Free Cash Flow is likely to remain negative over the next several quarters with merger transaction/integration costs continuing to present a cash flow headwind. /p>
<p>However, by the second half of 2022, the analysts expect many of these issues to vanish, also estimating the earnings/FCF-generating power of the company to start to become clearer. The analysts anticipate 2022 EBITDA to stand around 240 million. /p>
| NYSE:XPRO | https://financialmodelingprep.com/market-news/fmp-expro-group-holdings’-2022-outlook | Davit Kirakosyan | Financial Modeling Prep |
|
What Does Competitor’s Failure Mean to Alnylam Pharmaceuticals? | 2021-12-29 10:51:00 | <p>According to the announcement on Monday, BridgeBio Pharma, Inc. (NASDAQ:BBIO) acoramidis, the competitor of <a href='https://financialmodelingprep.com/financial-summary/ALNY'>Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)</a>, failed to significantly differentiate from placebo on 6MWD at 12 months in its Phase 3 trial in ATTR cardiomyopathy, the primary endpoint (p=0.76). </p>
<p>Despite this competitor disappointment, Alnylam Pharmaceuticals’ shares are weak, the possible reason of which can be the concerns that the unexpectedly strong performance seen in ATTRibute-CM's placebo group could similarly manifest in Apollo-B. </p>
<p>Analysts at Oppenheimer mentioned that they do not share the market's newfound skepticism and suggest buying the stock on weakness.</p>
| NASDAQ:ALNY | https://financialmodelingprep.com/market-news/fmp-what-does-competitor’s-failure-mean-to-alnylam-pharmaceuticals? | Davit Kirakosyan | Financial Modeling Prep |
|
Apple Shuts Down its Key Retail Stores in NYC Due to COVID | 2021-12-28 22:34:00 | <p><a href='https://financialmodelingprep.com/financial-summary/AAPL'>Apple Inc. (NASDAQ:AAPL) </a>announced it has shut down 16 retail stores across New York, including its key locations on Fifth Avenue, SoHo, Grand Central, and World Trade Center. The reason was to cope with the rising cases of Covid-19.</p>
<p>The company has shut down many of its retail stores in recent several weeks, however, it plans to implement a different approach with NYC locations. The company will allow its customers to shop online and pick the products up at the stores.</p>
| NASDAQ:AAPL | https://financialmodelingprep.com/market-news/fmp-apple-shuts-down-its-key-retail-stores-in-nyc-due-to-covid | Davit Kirakosyan | Financial Modeling Prep |
|
RR Donnelley & Sons Co Announces an Identified Systems Intrusion | 2021-12-28 22:32:00 | <p><a href='https://financialmodelingprep.com/financial-summary/RRD'>Donnelley & Sons Co (NYSE:RRD) </a>announced on Monday that it had identified a systems intrusion in its technical environment, while mentioning that currently, it is not able to determine the extent of the material adverse impact as the investigation is still in its early stages.</p>
<p>The company immediately performed a number of containment measures, including activating its incident response protocols, shutting down its servers and systems, and is actively engaged in implementing appropriate remedial actions in order to restore the affected systems and return to normal levels of operations.</p>
| NYSE:RRD | https://financialmodelingprep.com/market-news/fmp-rr-donnelley-&-sons-co-announces-an-identified-systems-intrusion- | Davit Kirakosyan | Financial Modeling Prep |
|
Bitcoin Drops Below $48,000 as $6 Billion Options Are Set to Expire on Friday | 2021-12-28 22:27:00 | <p>Bitcoin price dropped to around $47,500 on Tuesday, below its 200-day moving average, ahead of the expiration of a total of 129,800 option contracts on Friday, which are worth around $6 billion.</p>
<p>According to previous reports from CoinDesk, historical data shows that Bitcoin tends to move toward its “max pain” point as the expiration of options nears and shows a solid directional move after settlement.</p>
| BTCUSD | https://financialmodelingprep.com/market-news/fmp-bitcoin-drops-below-$48000-as-$6-billion-options-are-set-to-expire-on-friday | Davit Kirakosyan | Financial Modeling Prep |
|
Bank of Russia Seeks Crypto Restrictions | 2021-12-28 16:01:00 | <p>The Central Bank of Russia is reviewing several options to ban crypto investment, one of which is to block card payments to certain recipients such as crypto platforms, which are accused of conducting illegal operations by the regulator.</p>
<p>Another media report revealed that the Bank of Russia is planning to obtain additional data from financial institutions that process transfers between private individuals, including clients trading cryptos.</p>
| BTCUSD | https://financialmodelingprep.com/market-news/fmp-bank-of-russia-seeks-crypto-restrictions | Davit Kirakosyan | Financial Modeling Prep |